SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,051 | -16.1% | 302,897 | +12.4% | 0.00% | 0.0% |
| Q2 2023 | $1,253 | +109.5% | 269,497 | +108.3% | 0.00% | +100.0% |
| Q1 2023 | $598 | +147.1% | 129,397 | +332.8% | 0.00% | – |
| Q4 2022 | $242 | -100.0% | 29,900 | -86.2% | 0.00% | -100.0% |
| Q3 2022 | $1,198,000 | +55.6% | 215,900 | +46.2% | 0.00% | +100.0% |
| Q2 2022 | $770,000 | +6.2% | 147,700 | +203.3% | 0.00% | 0.0% |
| Q4 2021 | $725,000 | +11.2% | 48,700 | +62.3% | 0.00% | 0.0% |
| Q4 2020 | $652,000 | -43.8% | 30,014 | -79.9% | 0.00% | 0.0% |
| Q2 2020 | $1,160,000 | +926.5% | 149,513 | +1351.6% | 0.00% | – |
| Q4 2019 | $113,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |